{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:40:48Z","timestamp":1649032848170},"reference-count":28,"publisher":"Informa Healthcare","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2001,5]]},"DOI":"10.1517\/14656566.2.5.731","type":"journal-article","created":{"date-parts":[[2005,5,5]],"date-time":"2005-05-05T00:43:33Z","timestamp":1115253813000},"page":"731-737","source":"Crossref","is-referenced-by-count":2,"title":["The current status of antihypertensive treatments: into the new millennium"],"prefix":"10.1517","volume":"2","author":[{"given":"Timothy C","family":"Hardman","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Imperial College School of Medicine, Charing Cross Hospital, Fulham Palace Road, London W6 8RF, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin W","family":"Lunnon","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, GlaxoSmithKline Research and Development, Greenford, Middlesex, UB6 0HE, UK. mwl12467@GlaxoWellcome.co.uk"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2005,2,24]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.3.329"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03300-6"},{"issue":"91","key":"CIT0003","first-page":"97","volume":"2","author":"MEDICAL RESEARCH COUNCIL WORKING PARTY","year":"1985","journal-title":"Br. Med. J."},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.66.6.409"},{"key":"CIT0006","first-page":"1549","volume":"275","author":"GRIMM RH","year":"1996","journal-title":"Long-term effects on plasma lipids of diet and drugs to treat hypertension. JAMA"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530080036038"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001001"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02526-5"},{"key":"CIT0011","first-page":"1751","volume":"1999","author":"HANSSON L","journal-title":"Lancet"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)05012-0"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)04311-6"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.4.446"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1997.00440420033005"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7160.713"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.304.6824.405"},{"key":"CIT0019","first-page":"1967","volume":"283","author":"THE ALLHAT OFFICERS AND CO-ORDINATORS FOR THEALLHAT COLLABORATIVE RESEARCH GROUP","year":"2000","journal-title":"chlorthalidone. The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA"},{"key":"CIT0020","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0140-6736(00)02327-8","volume":"355","author":"BLOOD PRESSURE LOWERING TREATMENT TRIALISTS COLLABORATION","year":"2000","journal-title":"Lancet"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03306-7"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.32.6.989"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.35.6.1221"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200101043440101"},{"key":"CIT0026","first-page":"203","volume":"56","author":"O'BYRNE K","year":"1998","journal-title":"Therapeutics Implications. Drugs"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-199911010-00005"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.33.1.8"},{"key":"CIT0030","first-page":"1258","volume":"314","author":"BROWN MJ","year":"1997","journal-title":"Hypertension. Br. Med. J."},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03550030052033"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03510060059034"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.3.698"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14656566.2.5.731","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T13:59:18Z","timestamp":1549979958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14656566.2.5.731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2005,2,24]]},"published-print":{"date-parts":[[2001,5]]}},"alternative-id":["10.1517\/14656566.2.5.731"],"URL":"https:\/\/doi.org\/10.1517\/14656566.2.5.731","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}